Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference

Rhea-AI Summary

Royalty Pharma plc (RPRX) will participate in a fireside chat at TD Cowen’s 44th Annual Health Care Conference on March 5, 2024, at 10:30 a.m. ET. The webcast will be available on Royalty Pharma’s website and archived for at least thirty days.

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 44^th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. ET.

The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/. The webcast will also be archived for a minimum of thirty days.

About Royalty Pharma

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. For more information, visit www.royaltypharma.com.

Royalty Pharma Investor Relations and Communications

+1 (212) 883-6637
ir@royaltypharma.com

FAQ

When will Royalty Pharma plc participate in a fireside chat at TD Cowen’s 44th Annual Health Care Conference?

Royalty Pharma plc (RPRX) will participate in a fireside chat at TD Cowen’s 44th Annual Health Care Conference on March 5, 2024.

Where can I access the webcast of the event?

The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/.

For how long will the webcast be archived?

The webcast will be archived for a minimum of thirty days.